This website is intended exclusively for healthcare professionals residing and/or working in the UAE.
CENRIFKI (tolebrutinib) was studied in a range of patients with nrSPMS1,2
Diabetes
Dermatology
Cardiology
Vaccines
Rare Disease
Neurology
Rare Blood Disorders
Respiratory
Hematology
Rhinology
Other topics
Transplant
Gastroenterology